These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11678184)

  • 1. Microarray sampling-platform fabrication using bubble-jet technology for a biochip system.
    Allain LR; Askari M; Stokes DL; Vo-Dinh T
    Fresenius J Anal Chem; 2001 Sep; 371(2):146-50. PubMed ID: 11678184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous detection of the tumor suppressor FHIT gene and protein using the multi-functional biochip.
    Askari MD; Miller GH; Vo-Dinh T
    Cancer Detect Prev; 2002; 26(5):331-42. PubMed ID: 12518863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microarray fabrication with covalent attachment of DNA using bubble jet technology.
    Okamoto T; Suzuki T; Yamamoto N
    Nat Biotechnol; 2000 Apr; 18(4):438-41. PubMed ID: 10748527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of the human fragile histidine triad gene at 3p14.2 in monochromosomal human/mouse microcell hybrid-derived severe combined immunodeficient mouse tumors.
    Kholodnyuk ID; Szeles A; Yang Y; Klein G; Imreh S
    Cancer Res; 2000 Dec; 60(24):7119-25. PubMed ID: 11156420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma.
    Kuroki T; Trapasso F; Yendamuri S; Matsuyama A; Alder H; Mori M; Croce CM
    Cancer Res; 2003 Jul; 63(13):3724-8. PubMed ID: 12839965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel approach to simultaneously scan genes at fragile sites.
    Willem P; Brown J; Schouten J
    BMC Cancer; 2006 Aug; 6():205. PubMed ID: 16895604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precise localization of the FHIT gene to the common fragile site at 3p14.2 (FRA3B) and characterization of homozygous deletions within FRA3B that affect FHIT transcription in tumor cell lines.
    Ong ST; Fong KM; Bader SA; Minna JD; Le Beau MM; McKeithan TW; Rassool FV
    Genes Chromosomes Cancer; 1997 Sep; 20(1):16-23. PubMed ID: 9290949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FHIT gene alterations in esophageal cancer and ulcerative colitis (UC).
    Zou TT; Lei J; Shi YQ; Yin J; Wang S; Souza RF; Kong D; Shimada Y; Smolinski KN; Greenwald BD; Abraham JM; Harpaz N; Meltzer SJ
    Oncogene; 1997 Jul; 15(1):101-5. PubMed ID: 9233782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microcontact printing of DNA molecules.
    Lange SA; Benes V; Kern DP; Hörber JK; Bernard A
    Anal Chem; 2004 Mar; 76(6):1641-7. PubMed ID: 15018562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential cancer therapy with the fragile histidine triad gene: review of the preclinical studies.
    Ishii H; Dumon KR; Vecchione A; Fong LY; Baffa R; Huebner K; Croce CM
    JAMA; 2001 Nov; 286(19):2441-9. PubMed ID: 11712940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression.
    Ji L; Fang B; Yen N; Fong K; Minna JD; Roth JA
    Cancer Res; 1999 Jul; 59(14):3333-9. PubMed ID: 10416589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restored expression of fragile histidine triad protein and tumorigenicity of cervical carcinoma cells.
    Wu R; Connolly DC; Dunn RL; Cho KR
    J Natl Cancer Inst; 2000 Feb; 92(4):338-44. PubMed ID: 10675384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analysis of the fragile histidine triad (FHIT) tumor suppressor gene in vesical tumors of cattle with chronic enzootic hematuria (CEH).
    Guidi E; Uboldi C; Ferretti L
    Cytogenet Genome Res; 2008; 120(1-2):173-7. PubMed ID: 18467844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation of the 5' CpG island of the FHIT gene is closely associated with transcriptional inactivation in esophageal squamous cell carcinomas.
    Tanaka H; Shimada Y; Harada H; Shinoda M; Hatooka S; Imamura M; Ishizaki K
    Cancer Res; 1998 Aug; 58(15):3429-34. PubMed ID: 9699676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expression.
    Werner NS; Siprashvili Z; Fong LY; Marquitan G; Schröder JK; Bardenheuer W; Seeber S; Huebner K; Schütte J; Opalka B
    Cancer Res; 2000 Jun; 60(11):2780-5. PubMed ID: 10850413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletions of BRCA1/2 and p53 R248W gain-of-function mutation suggest impaired homologous recombination repair in fragile histidine triad-negative sebaceous gland carcinomas.
    Becker K; Goldberg M; Helmbold P; Holbach LM; Loeffler KU; Ballhausen WG
    Br J Dermatol; 2008 Dec; 159(6):1282-9. PubMed ID: 18717684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The FHIT gene at 3p14.2 is abnormal in breast carcinomas.
    Negrini M; Monaco C; Vorechovsky I; Ohta M; Druck T; Baffa R; Huebner K; Croce CM
    Cancer Res; 1996 Jul; 56(14):3173-9. PubMed ID: 8764101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the expression profile of apoptotic esophageal cancer cells by adenoviral-fragile histidine triad treatment.
    Mimori K; Ishii H; Inoue H; Barnard GF; Mori M
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S205-9. PubMed ID: 19120899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of ectogenous FHIT gene on reversing malignant phenotype of human lung adenocarcinoma cells A549].
    Wang Y; Zhuo Q; Qin Y; Yuan S; Sun Z; Wang Y; Chen X; Sun Z; Song Y; Yang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):225-9. PubMed ID: 12048684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors.
    Greenspan DL; Connolly DC; Wu R; Lei RY; Vogelstein JT; Kim YT; Mok JE; Muñoz N; Bosch FX; Shah K; Cho KR
    Cancer Res; 1997 Nov; 57(21):4692-8. PubMed ID: 9354423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.